Release Date: 29/04/14 12:09 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 752.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%